| 发明名称 |
CRYSTALLINE FORM OF VSN16 |
| 摘要 |
The present invention relates to a compound of formula (I) in crystalline form, wherein said compound is in the form of the free base or a pharmaceutically acceptable salt thereof, or a solvate of the free base or salt form thereof. The invention also relates to a pharmaceutical composition containing said crystalline form as an active ingredient, and use thereof in the prevention or treatment of disease. The invention further relates to a process for preparing the crystalline form.; |
| 申请公布号 |
US2015353476(A1) |
申请公布日期 |
2015.12.10 |
| 申请号 |
US201414760592 |
申请日期 |
2014.01.17 |
| 申请人 |
CARBEX THERAPEUTICS LIMITED |
发明人 |
Selwood David |
| 分类号 |
C07C233/69 |
主分类号 |
C07C233/69 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A crystalline form of the compound of formula (I) wherein said compound is in the form of the free base or a pharmaceutically acceptable salt thereof, or a solvate of the free base or salt form thereof. |
| 地址 |
Greater London GB |
